2 4 CDMO/CMO Partnerships Big Pharma Demos Find out how GLP-1 Technology can aid you in solving your issue No Peptide Team to access the market
Without insurance coverage, a $499 monthly option is available
If you want brand-name product, look at manufacturer self-pay programs
2 1-2 - 2 , 1-2 - 270 135 47% You've reached the max limit for this item
(2025) T2DM: 46.5% discontinued by 1 year 64.1% discontinued by 2 years Without T2DM: 64.8% discontinued by 1 year 84.4% discontinued by 2 years Key Factors Linked to Discontinuation: Higher rates among patients without T2DM Age 65 years More likely to discontinue Higher weight loss during treatment Associated with lower discontinuation rates Moderate to severe GI side effects Higher likelihood of stopping treatment Higher income (T2DM only) Lower discontinuation rates Reinitiation of GLP-1: Source: Rodriguez PJ, Zhang V, Gratzl S, et al
BPC-157 for muscle repair supports tissue regeneration, allowing muscles to recover quicker and function efficiently
